Market Tracker

07/03 11:22am ET

Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

11.98
Delayed Data
As of Jul 02
 -0.12 / -0.99%
Today’s Change
5.53
Today|||52-Week Range
13.84
+5.97%
Year-to-Date

Today’s Trading

Previous close12.10
Today’s open12.12
Day’s range11.88 - 12.14
Volume475,136
Average volume (3 months)1,282,358
Market cap$1.4B
Dividend yield--
Data as of 3:59pm ET, 07/02/2015

Growth & Valuation

Earnings growth (last year)+39.39%
Earnings growth (this year)-43.96%
Earnings growth (next 5 years)+5.61%
Revenue growth (last year)+115.03%
P/E ratioNM
Price/Sales11.48
Price/Book--

Competitors

 Today’s
change
Today’s
% change
RGENRepligen Corp-1.17-2.84%
ZSPHZS Pharma Inc+0.84+1.49%
TXMDTherapeuticsMD Inc+0.06+0.73%
ACORAcorda Therapeutics ...-0.01-0.03%
Data as of 4:00pm ET, 07/02/2015

Financials

Next reporting dateAugust 6, 2015
EPS forecast (this quarter)-$0.30
Annual revenue (last year)$102.8M
Annual profit (last year)-$83.3M
Net profit margin-81.06%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert J. Mulroy
Head-
Corporate Operations
William M. McClements
Corporate headquarters
Cambridge, Massachusetts

Forecasts